|
Regulatory
Posted By:
Trace One
The Authorization process
The aim of the REACH authorisation process is to ensure that the risks from using substances of very high concern (SVHC) are properly controlled and that SVHCs are progressively replaced by less dangerous substances or technologies, where technically and economically feasible alternatives are available.
ECHA can propose the inclusion of one or more substances to Annex XIV to REACH regulation to the European Commission which, together with the EU Member States and the European Parliament, will express an opinion on the matter.
As provided for in the Title VII and in the Articles from 55 to 66 of REACH regulation, for each substance included in Annex XIV, and therefore subjected to the authorisation procedure, the transitional provisions involving two dates settled as follows:
- The expiration date from which the placing on the market and the use of the substance are forbidden, unless specifically approved (art. 58.1 letter c), point i) of REACH);
- The date within which the Authorization requests for a particular use of the substance have to be sent (art. 58.1 letter c), point ii) of REACH);
Substances subject to these new proposals.
The following substances are object of these new proposals:
- Octamethylcyclotetrasiloxane (D4) (EC 209-136-7)
- Decamethylcyclopentasiloxane (D5) (EC 208-764-9);
- Dodecamethylcyclohexasiloxane (D6) (EC 208-762-8)
- Terphenyl, hydrogenated (EC 262-967-7)
- Dicyclohexyl phthalate (DCHP) (EC 201-545-9)
- Disodium octaborate (DCHP) (EC 234-541-0)
- Benzene-1,2,4-tricarboxylic acid 1,2-anhydride (trimellitic anhydride, TMA) (EC 209-008-0)
For more information, follow these links:
